Neuroscientific Basis of Dementia 2001
DOI: 10.1007/978-3-0348-8225-5_30
|View full text |Cite
|
Sign up to set email alerts
|

Catabolism of amyloid-β peptide in brain parenchyma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2001
2001
2001
2001

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…This possibility follows from studies showing that MMP‐2 and MMP‐9 proteolyse synthetic Aβ peptides (Miyazaki et al ., 1993; Backstrom et al ., 1996). We previously demonstrated that a neutral endopeptidase similar or identical to neprilysin initiates the in vivo catabolism of monomer Aβ in brain as a rate‐limiting step (Iwata et al ., 2000; Saido & Iwata, 2000). This enzyme, however, is capable of acting only on peptides smaller than 5000 in molecular weight (Oefner et al ., 2000), and is therefore unlikely to degrade fibrillar forms of Aβ.…”
Section: Introductionmentioning
confidence: 99%
“…This possibility follows from studies showing that MMP‐2 and MMP‐9 proteolyse synthetic Aβ peptides (Miyazaki et al ., 1993; Backstrom et al ., 1996). We previously demonstrated that a neutral endopeptidase similar or identical to neprilysin initiates the in vivo catabolism of monomer Aβ in brain as a rate‐limiting step (Iwata et al ., 2000; Saido & Iwata, 2000). This enzyme, however, is capable of acting only on peptides smaller than 5000 in molecular weight (Oefner et al ., 2000), and is therefore unlikely to degrade fibrillar forms of Aβ.…”
Section: Introductionmentioning
confidence: 99%